Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Rotavirus outer capsid glycoprotein VP7 and spike protein VP4 are the two primary structural proteins forming the outermost layer of the rotavirus virion [6, 15]. VP4 functions as a spike protein that mediates viral attachment to host cells and is proteolytically cleaved by trypsin into VP8* and VP5* subunits to facilitate membrane penetration [5, 12]. VP7 is a calcium-dependent glycoprotein that forms the bulk of the outer capsid and interacts with host co-receptors, such as integrins, to mediate viral entry and subsequent uncoating (decapsidation) within the host cell [2, 4, 16]. These proteins are the principal targets for neutralizing antibodies and serve as the basis for the G (glycoprotein) and P (protease-sensitive) dual classification system for rotavirus strains [1, 7, 14]. Therapeutic strategies, primarily live-attenuated vaccines like Rotarix and RotaTeq, target these proteins to elicit protective immunity against severe gastroenteritis in infants [8, 13, 18]. Ongoing research also explores monoclonal antibodies and subunit vaccines targeting specific domains of VP4 and VP7 to overcome challenges like antigenic diversity and vaccine-escape mutants [10, 13, 19].
Induction of neutralizing antibodies that inhibit viral attachment, membrane penetration, and virion decapsidation [5, 16, 18].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rotavirus outer capsid glycoprotein VP7 and spike protein VP4 (VP7 and VP4).